06.09.2017Anergis Announces Results of the ATIBAR TrialYou are hereNewsAnergis Announces Results of the ATIBAR Trial
Find an actor
MedTech Investing Europe 2018 (MTi)24.04.2018The 26th MedTech Investing Europe Conference will be held on 24 and 25 April 2018 at the Royal Savoy Hotel in...
Anergis and Mymetics Start Research Collaboration ProjectMymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines,...
DFB Pharmaceuticals Inc.Medical Devices, Consumables & ReagentsSummary of activity
DFB BioScience's primary focus is in the field of Cell Biology and Cell based therapies. The company develops Cell based therapies for treating chronic and acute wounds. Our R&D program includes several products at different development stage (preclinical, clinical, market approval). DFB BioScience can also provide manufacturing services for cell banking and Cell based products clinical manufacturing.
DFB BioScience is one of DFB Pharmaceuticals’ International branches. DFB Pharmaceuticals Inc., the mother company, is a fully integrated pharmaceutical group composed of two main divisions, DPT Laboratories, a Contract Manufacturing Organization providing customers with drug development and manufacturing services, and Healthpoint, which develops & markets pharmaceutical and medical products for chronic wounds.